Cargando…
Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
The emergence of new platforms for the discovery of innovative therapeutics has provided a means for diagnosing cardiac disease in its early stages. Taking into consideration the global health burden of cardiac disease, clinicians require innovations in medical diagnostics that can be used for risk...
Autores principales: | Chugh, Shaan, Suen, Colin, Gramolini, Anthony |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892078/ https://www.ncbi.nlm.nih.gov/pubmed/21532779 http://dx.doi.org/10.2174/157340310791162631 |
Ejemplares similares
-
Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013) -
What have we learned and what do we still need to learn about nPDF?
por: Paakkinen, Petja
Publicado: (2021) -
What Have We Learned about the Microbiomes of Indoor Environments?
por: Stephens, Brent
Publicado: (2016) -
Taming the Huntington’s Disease Proteome: What Have We Learned?
por: Seeley, Connor, et al.
Publicado: (2021) -
What are we learning about supersymmetry from not having discovered it yet?
por: Pokorski, Stefan, et al.
Publicado: (1998)